Michael Knauer

Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial

Viviana Galimberti, Bernard F. Cole, Giuseppe Viale et al. · The Lancet Oncology · 2018 · 533 citations

Surgical Oncology, Breast Oncology, Medicine +7

Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone

Michael Gnant, Martin Filipits, Richard Greil et al. · Annals of Oncology · 2013 · 392 citations · Full text

Surgical Oncology, Breast Oncology, Recurrence Score +10

Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12

Michael Gnant, Brigitte Mlineritsch, Herbert Stoeger et al. · Annals of Oncology · 2014 · 300 citations · Full text

Zoledronic Acid, Breast Oncology, Endocrine Oncology +12

A prospective evaluation of a breast cancer prognosis signature in the observational RASTER study

Caroline A. Drukker, J.M. Bueno-De-Mesquita, Valesca P. Retèl et al. · International Journal of Cancer · 2013 · 224 citations · Full text

Breast Oncology, Cancer Management, Epidemiology Of Cancer +22

The PAM50 Risk-of-Recurrence Score Predicts Risk for Late Distant Recurrence after Endocrine Therapy in Postmenopausal Women with Endocrine-Responsive Early Breast Cancer

Martin Filipits, Torsten O. Nielsen, Margaretha Rudas et al. · Clinical Cancer Research · 2014 · 203 citations